BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35657579)

  • 21. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic site discriminates survival benefit of primary tumor surgery for differentiated thyroid cancer with distant metastases: A real-world observational study.
    Ding W; Ruan G; Zhu J; Tu C; Li Z
    Medicine (Baltimore); 2020 Nov; 99(48):e23132. PubMed ID: 33235073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.
    Nguyen XV; Roy Choudhury K; Tessler FN; Hoang JK
    Thyroid; 2018 Mar; 28(3):295-300. PubMed ID: 29373949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
    Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
    Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of prior malignancy history in stage I differentiated thyroid cancer: a SEER-based study.
    Wang Y; Li S; Xu F; Hao Q
    Transl Cancer Res; 2023 May; 12(5):1241-1253. PubMed ID: 37304545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
    Fischer-Valuck BW; Michalski JM; Contreras JA; Brenneman R; Christodouleas JP; Abraham CD; Kim EH; Arora VK; Bullock AD; Carmona R; Figenshau RS; Grubb R; Knoche EM; Pachynski RK; Picus J; Roth BJ; Sargos P; Andriole GL; Gay HA; Baumann BC
    Clin Transl Radiat Oncol; 2019 Feb; 15():38-41. PubMed ID: 30656221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
    Oh HS; Shin DY; Kim M; Park SY; Kim TH; Kim BH; Kim EY; Kim WB; Chung JH; Shong YK; Lim DJ; Kim WG
    Thyroid; 2019 Dec; 29(12):1804-1810. PubMed ID: 31592739
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis.
    Kim HJ; Lee JI; Kim NK; Min YK; Kim SW; Chung JH
    World J Surg; 2013 Dec; 37(12):2845-52. PubMed ID: 24085223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
    Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
    Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
    Schvartz C; Bonnetain F; Dabakuyo S; Gauthier M; Cueff A; Fieffé S; Pochart JM; Cochet I; Crevisy E; Dalac A; Papathanassiou D; Toubeau M
    J Clin Endocrinol Metab; 2012 May; 97(5):1526-35. PubMed ID: 22344193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital.
    Lim II; Hochman T; Blumberg SN; Patel KN; Heller KS; Ogilvie JB
    Thyroid; 2012 Mar; 22(3):269-74. PubMed ID: 22233131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
    Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
    Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Care Fragmentation in Patients with Differentiated Thyroid Cancer.
    Greenberg JA; Thiesmeyer JW; Egan CE; Lee YJ; Sivarajah M; Zarnegar R; Fahey TJ; Beninato T; Finnerty BM
    World J Surg; 2022 Dec; 46(12):3007-3016. PubMed ID: 36038731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic factors for differentiated thyroid carcinoma and review of the literature.
    Zhao Y; Zhang Y; Liu XJ; Shi BY
    Tumori; 2012; 98(2):233-7. PubMed ID: 22677990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
    Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
    PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
    Goffredo P; Roman SA; Sosa JA
    Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
    Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
    Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.